96 related articles for article (PubMed ID: 2656331)
1. Adjuvant PSK immunotherapy in patients with carcinoma of the nasopharynx.
Go P; Chung CH
J Int Med Res; 1989; 17(2):141-9. PubMed ID: 2656331
[TBL] [Abstract][Full Text] [Related]
2. PSK immunotherapy in cancer patients--a preliminary report.
Chung CH; Go P; Chang KH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):210-6. PubMed ID: 3322700
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
Dis Colon Rectum; 1992 Feb; 35(2):123-30. PubMed ID: 1735313
[TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
6. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK.
Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
Anticancer Res; 1997; 17(4A):2815-8. PubMed ID: 9252721
[TBL] [Abstract][Full Text] [Related]
7. [Compound therapy including PSK for malignant head and neck cancer].
Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
[TBL] [Abstract][Full Text] [Related]
8. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].
Mitomi T; Tsuchiya S; Iijima N; Aso K; Suzuki K; Nishiyama K; Amano T; Takahashi T; Murayama N; Oka H
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2241-9. PubMed ID: 2500070
[TBL] [Abstract][Full Text] [Related]
9. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Ichihashi H; Kondo T; Nakazato H
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
[TBL] [Abstract][Full Text] [Related]
11. [The effect of PSK on laryngeal cancer].
Saito H; Hozawa J; Kamata S; Hakamada M; Kasahara M; Takagi A
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1061-7. PubMed ID: 7184440
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
13. [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer].
Nakazato H; Koike A; Ichihashi H; Saji S; Danno M; Ogawa N
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2563-76. PubMed ID: 2505682
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan.
Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
Am J Clin Oncol; 1995 Jun; 18(3):216-22. PubMed ID: 7747709
[TBL] [Abstract][Full Text] [Related]
15. Preoperative CEA and PPD values as prognostic factors for immunochemotherapy using PSK and 5-FU.
Takahashi Y; Mai M; Nakazato H
Anticancer Res; 2005; 25(2B):1377-84. PubMed ID: 15865094
[TBL] [Abstract][Full Text] [Related]
16. Effect of Krestin as adjuvant treatment following radical radiotherapy in non-small cell lung cancer patients.
Hayakawa K; Mitsuhashi N; Saito Y; Nakayama Y; Furuta M; Nakamoto S; Kawashima M; Niibe H
Cancer Detect Prev; 1997; 21(1):71-7. PubMed ID: 9043766
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of immunotherapy with PSK in esophageal cancer].
Ogoshi K
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3143-51. PubMed ID: 3056280
[TBL] [Abstract][Full Text] [Related]
18. [A cooperative study of alternating immunochemotherapy with futraful and PSK (second report)--3-year survival rate].
Ichihashi H; Kondo T; Yamauchi M; Isomatsu T; Nakamura T; Sakabe T; Nakajima T; Ikenaga T; Shiratori T; Taguchi T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):331-6. PubMed ID: 3918509
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant immunotherapy for carcinoma of uterine cervix with PSK].
Shiraki S; Mori H; Ito A; Kadomoto N; Yamagiwa S; Yamada Y; Noda K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1031-9. PubMed ID: 6985193
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.
Tsujitani S; Kakeji Y; Orita H; Watanabe A; Kohnoe S; Baba H; Anai H; Maehara Y; Sugimachi K
Anticancer Res; 1992; 12(3):645-8. PubMed ID: 1622120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
